Optimization of Anticoagulants Treatment Plan for One Case of Breast Cancer Complicated with Venous Thromboembolism
10.6039/j.issn.1001-0408.2016.05.45
- VernacularTitle:1例乳腺癌合并静脉血栓栓塞患者的抗凝方案优化
- Author:
Chenlu LI
;
Hongming PAN
;
Lirong SHEN
;
Hua SHAO
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Venous thromboembolism;
Warfarin;
Clinical pharmacist;
Pharmaceutical care
- From:
China Pharmacy
2016;27(5):708-710
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore optimization method and effect of clinical pharmacists on anticoagulants therapy plan for cancer patient with venous thromboembolism(VTE). METHODS:Clinical pharmacists participated in the whole process of antico-agulant therapy for one case of breast cancer complicated with VTE. Clinical pharmacists suggested patient to initially take low mo-lecular weight heparin sodium 0.6 ml,sc,qd;and then take Warfarin sodium tablet 3 mg,po,qd;initial plan and oral dosage form plan superimposed and alternated,and pharmaceutical care and medication education were also provided for the patient. RESULTS:Physicians adopted clinical pharmacist's suggestions,and the patient received anticoagulant therapy for 27 days and paclitaxel che-motherapy once. Coagulation function INR was 2.71;the patient didn't felt discomfort and then discharged from hospital. CON-CLUSIONS:The participation of clinical pharmacists in the optimization of individualized anticoagulant therapy and pharmaceutical care is able to promote rational drug use,prevent severe ADR in the clinic,guarantee the safety of drug use and improve medica-tion compliance.
